This inventor holds 2 USPTO granted patents. Top assignee: Huels Aktiengesellschaft. Active years: 1999-2000.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1999-2000
Title: Guenter Lorenz: Innovator in Antimicrobial Surface Technology
Introduction
Guenter Lorenz is a notable inventor based in Marl, Germany. He has made significant contributions to the field of antimicrobial surface technology, holding 2 patents that focus on enhancing blood compatibility and microbial control in medical applications.
Latest Patents
One of his latest patents is a method of making a blood-compatible antimicrobial surface. This innovative method provides articles with surfaces designed to control the spread of microbes while ensuring blood compatibility. Such advancements are crucial in the medical field, where the elimination of infection-causing microbes and the reduction of dangerous blood clots in patients are of utmost importance. Another significant patent by Lorenz is related to the hydrophilic coating of surfaces of polymeric substrates. This patent describes a process for preparing a hydrophilic coating on a polymeric substrate through radiation-induced graft polymerization on an activated substrate surface.
Career Highlights
Guenter Lorenz is associated with Huels Aktiengesellschaft, where he continues to develop and refine his innovative technologies. His work has had a profound impact on the medical industry, particularly in improving patient safety and treatment outcomes.
Collaborations
Throughout his career, Lorenz has collaborated with notable colleagues, including Hartwig Hoecker and Christine Anders. These partnerships have contributed to the advancement of his research and the successful implementation of his patented technologies.
Conclusion
Guenter Lorenz stands out as an influential inventor in the realm of antimicrobial surface technology. His patents reflect a commitment to improving medical safety and efficacy, making significant strides in the fight against infections and blood-related complications.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
